Logo image of CMBT

CMB TECH NV (CMBT) Stock Fundamental Analysis

NYSE:CMBT - New York Stock Exchange, Inc. - BE0003816338 - Common Stock - Currency: USD

9.18  +0.2 (+2.23%)

Fundamental Rating

4

Taking everything into account, CMBT scores 4 out of 10 in our fundamental rating. CMBT was compared to 208 industry peers in the Oil, Gas & Consumable Fuels industry. CMBT has an excellent profitability rating, but there are concerns on its financial health. CMBT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CMBT had positive earnings in the past year.
CMBT had a positive operating cash flow in the past year.
CMBT had positive earnings in 4 of the past 5 years.
Of the past 5 years CMBT 4 years had a positive operating cash flow.
CMBT Yearly Net Income VS EBIT VS OCF VS FCFCMBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

CMBT has a Return On Assets of 12.31%. This is amongst the best in the industry. CMBT outperforms 88.46% of its industry peers.
CMBT has a better Return On Equity (79.11%) than 96.15% of its industry peers.
The Return On Invested Capital of CMBT (5.33%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CMBT is significantly below the industry average of 23.99%.
The 3 year average ROIC (9.43%) for CMBT is well above the current ROIC(5.33%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 12.31%
ROE 79.11%
ROIC 5.33%
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.43%
ROIC(5y)N/A
CMBT Yearly ROA, ROE, ROICCMBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

CMBT has a better Profit Margin (72.50%) than 95.67% of its industry peers.
In the last couple of years the Profit Margin of CMBT has grown nicely.
With an excellent Operating Margin value of 35.88%, CMBT belongs to the best of the industry, outperforming 80.29% of the companies in the same industry.
In the last couple of years the Operating Margin of CMBT has grown nicely.
Looking at the Gross Margin, with a value of 58.65%, CMBT is in the better half of the industry, outperforming 66.35% of the companies in the same industry.
In the last couple of years the Gross Margin of CMBT has remained more or less at the same level.
Industry RankSector Rank
OM 35.88%
PM (TTM) 72.5%
GM 58.65%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
CMBT Yearly Profit, Operating, Gross MarginsCMBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CMBT is creating some value.
The number of shares outstanding for CMBT has been reduced compared to 1 year ago.
CMBT has less shares outstanding than it did 5 years ago.
CMBT has a worse debt/assets ratio than last year.
CMBT Yearly Shares OutstandingCMBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBT Yearly Total Debt VS Total AssetsCMBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.66, we must say that CMBT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.66, CMBT is doing worse than 62.02% of the companies in the same industry.
CMBT has a Debt/Equity ratio of 3.75. This is a high value indicating a heavy dependency on external financing.
CMBT has a worse Debt to Equity ratio (3.75) than 86.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Altman-Z 0.66
ROIC/WACC0.71
WACC7.5%
CMBT Yearly LT Debt VS Equity VS FCFCMBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

CMBT has a Current Ratio of 0.77. This is a bad value and indicates that CMBT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.77, CMBT is doing worse than 71.15% of the companies in the same industry.
CMBT has a Quick Ratio of 0.77. This is a bad value and indicates that CMBT is not financially healthy enough and could expect problems in meeting its short term obligations.
CMBT has a worse Quick ratio (0.70) than 68.27% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.7
CMBT Yearly Current Assets VS Current LiabilitesCMBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

CMBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -79.01%.
CMBT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 43.41% yearly.
The Revenue for CMBT has decreased by -20.34% in the past year. This is quite bad
CMBT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.55% yearly.
EPS 1Y (TTM)-79.01%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-100.41%
Revenue 1Y (TTM)-20.34%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-2.22%

3.2 Future

The Earnings Per Share is expected to decrease by -29.06% on average over the next years. This is quite bad
Based on estimates for the next years, CMBT will show a very strong growth in Revenue. The Revenue will grow by 26.43% on average per year.
EPS Next Y-69.07%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
EPS Next 5YN/A
Revenue Next Year31.15%
Revenue Next 2Y28.49%
Revenue Next 3Y26.43%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CMBT Yearly Revenue VS EstimatesCMBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CMBT Yearly EPS VS EstimatesCMBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

6

4. Valuation

4.1 Price/Earnings Ratio

CMBT is valuated cheaply with a Price/Earnings ratio of 7.46.
Based on the Price/Earnings ratio, CMBT is valued cheaply inside the industry as 83.65% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.24, CMBT is valued rather cheaply.
CMBT is valuated cheaply with a Price/Forward Earnings ratio of 5.51.
90.38% of the companies in the same industry are more expensive than CMBT, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 36.42. CMBT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.46
Fwd PE 5.51
CMBT Price Earnings VS Forward Price EarningsCMBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CMBT's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.62
CMBT Per share dataCMBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

The decent profitability rating of CMBT may justify a higher PE ratio.
A cheap valuation may be justified as CMBT's earnings are expected to decrease with -29.06% in the coming years.
PEG (NY)N/A
PEG (5Y)0.17
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%

0

5. Dividend

5.1 Amount

CMBT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CMB TECH NV

NYSE:CMBT (8/4/2025, 8:04:00 PM)

9.18

+0.2 (+2.23%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-21 2025-05-21/bmo
Earnings (Next)08-28 2025-08-28/bmo
Inst Owners1.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.02B
Analysts80
Price Target12.83 (39.76%)
Short Float %5.75%
Short Ratio8.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend5.68
Dividend Growth(5Y)116.35%
DP109.72%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-99.31%
Min EPS beat(2)-149.02%
Max EPS beat(2)-49.61%
EPS beat(4)1
Avg EPS beat(4)9.95%
Min EPS beat(4)-149.02%
Max EPS beat(4)242.1%
EPS beat(8)5
Avg EPS beat(8)86.48%
EPS beat(12)8
Avg EPS beat(12)69.92%
EPS beat(16)10
Avg EPS beat(16)53.9%
Revenue beat(2)1
Avg Revenue beat(2)0.7%
Min Revenue beat(2)-9.81%
Max Revenue beat(2)11.21%
Revenue beat(4)3
Avg Revenue beat(4)5.75%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)15.33%
Revenue beat(8)6
Avg Revenue beat(8)28.28%
Revenue beat(12)10
Avg Revenue beat(12)38.19%
Revenue beat(16)14
Avg Revenue beat(16)43.66%
PT rev (1m)-5.12%
PT rev (3m)-6.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)22.4%
Revenue NY rev (3m)22.4%
Valuation
Industry RankSector Rank
PE 7.46
Fwd PE 5.51
P/S 1.45
P/FCF N/A
P/OCF 7.52
P/B 1.58
P/tB 1.85
EV/EBITDA 10.62
EPS(TTM)1.23
EY13.4%
EPS(NY)1.67
Fwd EY18.16%
FCF(TTM)-4.28
FCFYN/A
OCF(TTM)1.22
OCFY13.29%
SpS6.35
BVpS5.82
TBVpS4.96
PEG (NY)N/A
PEG (5Y)0.17
Profitability
Industry RankSector Rank
ROA 12.31%
ROE 79.11%
ROCE 6.75%
ROIC 5.33%
ROICexc 5.45%
ROICexgc 5.6%
OM 35.88%
PM (TTM) 72.5%
GM 58.65%
FCFM N/A
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.43%
ROIC(5y)N/A
ROICexc(3y)10.41%
ROICexc(5y)N/A
ROICexgc(3y)10.46%
ROICexgc(5y)N/A
ROCE(3y)11.93%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.98%
ROICexc growth 3YN/A
ROICexc growth 5Y15.87%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
F-Score2
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Debt/EBITDA 7.03
Cap/Depr 666.34%
Cap/Sales 86.55%
Interest Coverage 3.85
Cash Conversion 39.32%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.7
Altman-Z 0.66
F-Score2
WACC7.5%
ROIC/WACC0.71
Cap/Depr(3y)357.13%
Cap/Depr(5y)252.34%
Cap/Sales(3y)69.97%
Cap/Sales(5y)65.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.01%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-100.41%
EPS Next Y-69.07%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-20.34%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-2.22%
Revenue Next Year31.15%
Revenue Next 2Y28.49%
Revenue Next 3Y26.43%
Revenue Next 5YN/A
EBIT growth 1Y-38.91%
EBIT growth 3YN/A
EBIT growth 5Y15.35%
EBIT Next Year67.95%
EBIT Next 3Y22.95%
EBIT Next 5YN/A
FCF growth 1Y-783.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.61%
OCF growth 3YN/A
OCF growth 5Y11.04%